Type 1 Diabetes Trial, Recruiting (NCT06875167)

Type 1 Diabetes Trial, Recruiting NCT06875167 Sponsor: Fondation Lenval Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06875167 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your child is between 2 and 6 years old (inclusive)
Your child has been diagnosed with type 1 diabetes and is currently on insulin therapy
Your child is covered by social security (French national health insurance)
Your child is just starting treatment with a semi-closed loop system (an automated insulin delivery device)
At least one parent or legal guardian agrees to complete the training needed to use a real-time continuous glucose monitoring system
At least one parent or legal guardian has given their agreement for the child to take part in the study

Who may not be able to join:

Families who do not wish to take part in medical research involving their child, or who object to their child's data or samples being used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Céline Gouillard-Darnaud, MD, Fondation Lenval

Phone: +33492030520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06875167

Sponsor: Fondation Lenval

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +33492030520

More information: https://clinicaltrials.gov/study/NCT06875167

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your child is between 2 and 6 years old (inclusive)
Your child has been diagnosed with type 1 diabetes and is currently on insulin therapy
Your child is covered by social security (French national health insurance)
Your child is just starting treatment with a semi-closed loop system (an automated insulin delivery device)
At least one parent or legal guardian agrees to complete the training needed to use a real-time continuous glucose monitoring system
At least one parent or legal guardian has given their agreement for the child to take part in the study

Who may not be able to join:

Families who do not wish to take part in medical research involving their child, or who object to their child's data or samples being used in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondation Lenval

Registry

ClinicalTrials.gov

Start date

17 March 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

An improvement in the score on the general quality of life questionnaire in pediatrics PedsQL 4.0 which will be evaluated before the implementation of the semi-closed loop, at 1 month and 6 months after the implementation of the semi-closed loop.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov